R S Kalish
Overview
Explore the profile of R S Kalish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gilhar A, Ullmann Y, Karry R, Shalaginov R, Assy B, Serafimovich S, et al.
Br J Dermatol
. 2004 Jan;
150(1):56-63.
PMID: 14746617
Background: Aged human epidermis is characterized by morphological changes including flattening of the dermal-epidermal junction and a decrease in thickness. Objectives: To determine the roles of proliferation, apoptosis, Fas (CD95),...
2.
Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish R
J Invest Dermatol
. 2002 Mar;
117(6):1357-62.
PMID: 11886495
Alopecia areata is a tissue restricted autoimmune condition affecting the hair follicle, resulting in hair loss. The goal of this study was to test the hypothesis that the autoantigen of...
3.
4.
5.
Wille J, Kydonieus A, Kalish R
Skin Pharmacol Appl Skin Physiol
. 2000 Apr;
13(2):65-74.
PMID: 10754454
New anti-irritant treatments are required to prevent irritation and sensitization reactions to consumer medicines and dermatological drugs. We report here that phenoxyacetic acid methyl ester (PAME) is an effective agent...
6.
Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish R
J Investig Dermatol Symp Proc
. 2000 Feb;
4(3):207-10.
PMID: 10674367
Much evidence suggests that alopecia areata is a tissue restricted autoimmune disease. Alopecia areata responds to immunosuppressive agents, and is associated with other tissue restricted autoimmune diseases, including autoimmune thyroiditis...
7.
8.
Wille J, Kydonieus A, Kalish R
Skin Pharmacol Appl Skin Physiol
. 1999 May;
12(1-2):12-7.
PMID: 10325579
A major obstacle in transdermal delivery of drugs is the development of adverse skin sensitization reactions. We tested the concept that ion channel modulators as a class of agents suppress...
9.
Kalish R, Askenase P
J Allergy Clin Immunol
. 1999 Feb;
103(2 Pt 1):192-9.
PMID: 9949307
Delayed-type hypersensitivity (DTH) is defined as the recruitment of T cells into tissues to be activated by antigen-presenting cells to produce cytokines that mediate local inflammation. CD8+ T cells are...
10.
Wille J, Kydonieus A, Kalish R
Skin Pharmacol Appl Skin Physiol
. 1999 Jan;
11(4-5):279-88.
PMID: 9885413
The immunosuppressive effect of topical ethacrynic acid (ECA) was tested on both the induction and elicitation phases of contact sensitization in a mouse model. ECA (0.5% in vehicle) reduced the...